title: Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.
abstract: Deposition of PrP amyloid in cerebral vessels in conjunction with neurofibrillary lesions is the neuropathologic hallmark of the dementia associated with a stop mutation at codon 145 of PRNP, the gene encoding the prion protein (PrP). In this disorder, the vascular amyloid in tissue sections and the approximately 7.5-kDa fragment extracted from amyloid are labeled by antibodies to epitopes located in the PrP sequence including amino acids 90-147. Amyloid-laden vessels are also labeled by antibodies against the C terminus, suggesting that PrP from the normal allele is involved in the pathologic process. Abundant neurofibrillary lesions are present in the cerebral gray matter. They are composed of paired helical filaments, are labeled with antibodies that recognize multiple phosphorylation sites in tau protein, and are similar to those observed in Alzheimer disease. A PrP cerebral amyloid angiopathy has not been reported in diseases caused by PRNP mutations or in human transmissible spongiform encephalopathies; we propose to name this phenotype PrP cerebral amyloid angiopathy (PrP-CAA).
authors.affiliation: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis 46202-5120, USA.
authors.forename: B
authors.initials: B
authors.lastname: Ghetti
authors.forename: P
authors.initials: P
authors.lastname: Piccardo
authors.forename: M G
authors.initials: MG
authors.lastname: Spillantini
authors.forename: Y
authors.initials: Y
authors.lastname: Ichimiya
authors.forename: M
authors.initials: M
authors.lastname: Porro
authors.forename: F
authors.initials: F
authors.lastname: Perini
authors.forename: T
authors.initials: T
authors.lastname: Kitamoto
authors.forename: J
authors.initials: J
authors.lastname: Tateishi
authors.forename: C
authors.initials: C
authors.lastname: Seiler
authors.forename: B
authors.initials: B
authors.lastname: Frangione
authors.forename: O
authors.initials: O
authors.lastname: Bugiani
authors.forename: G
authors.initials: G
authors.lastname: Giaccone
authors.forename: F
authors.initials: F
authors.lastname: Prelli
authors.forename: M
authors.initials: M
authors.lastname: Goedert
authors.forename: S R
authors.initials: SR
authors.lastname: Dlouhy
authors.forename: F
authors.initials: F
authors.lastname: Tagliavini
mesh_terms: D000328:Adult; D000682:Amyloid / Q000737:chemistry; D001808:Blood Vessels / Q000473:pathology; D016657:Cerebral Amyloid Angiopathy / Q000473:pathology*; D002540:Cerebral Cortex / Q000473:pathology; D003704:Dementia / Q000209:etiology*; D005260:Female; D006801:Humans; D007564:Japan / Q000208:ethnology; D009154:Mutation; D009474:Neurons / Q000473:pathology; D010641:Phenotype; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D011328:Prions / Q000235:genetics* / Q000276:immunology
chemical_list: D000682:Amyloid; D011328:Prions